XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income tax expense for the three months ended March 31, 2024 was approximately $1.1 million on pre-tax loss of $12.4 million. Income tax expense for the three months ended March 31, 2023 was approximately $2.5 million on pre-tax loss of $17.6 million.
As of March 31, 2024, the income tax rate varied from the United States statutory income tax rate primarily due to valuation allowances in North America, and EMEA, mandatory R&D expense capitalization in the U.S., and foreign and state income tax rate differentials. Consistent with the prior periods, the Company continued to maintain valuation allowances in North America and EMEA.
The total amount of unrecognized tax benefits, including interest and penalties, as of March 31, 2024 was $5.2 million. There were no significant changes to unrecognized tax benefits during the three months ended March 31, 2024. The Company does not anticipate any significant changes with respect to unrecognized tax benefits within the next twelve months